Kalundborg, Denmark

Simon Glanville

This inventor holds 1 USPTO granted patent and 4 published patent applications and 2 EPO patents. Top assignee: Novozymes A/s. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Simon Glanville. Retrieved from https://idiyas.com/inventor/simon-glanville

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Simon Glanville

Introduction

Simon Glanville is a notable inventor based in Kalundborg, Denmark. He has made significant contributions to the field of biotechnology, particularly in the area of metabolite recovery. His innovative approach has the potential to enhance the efficiency of fermentation processes in various industries.

Latest Patents

Simon Glanville holds a patent for a method titled "Crystal metabolite recovery." This patent describes a process for producing a crystalline and/or amorphous metabolite suspension from a cell fermentation broth using a continuous centrifuge process. The method involves several steps, including the addition of fermentation broth and an aqueous liquid with specific density characteristics, followed by the removal of cells and the suspension of the desired metabolite.

Career Highlights

Simon Glanville is currently employed at Novozymes A/S, a leading company in the biotechnology sector. His work focuses on developing innovative solutions that improve the efficiency of bioprocesses. With a patent portfolio that includes 1 patent, he continues to contribute to advancements in his field.

Collaborations

Throughout his career, Simon has collaborated with talented individuals such as Sune Jakobsen and Svend Gunnar Kaasgaard. These collaborations have fostered a creative environment that encourages innovation and the sharing of ideas.

Conclusion

Simon Glanville's contributions to the field of biotechnology, particularly through his patented methods, highlight his role as an influential inventor. His work at Novozymes A/S and collaborations with colleagues further emphasize his commitment to advancing biotechnological processes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…